197 related articles for article (PubMed ID: 38497715)
21. Streptococcus and Prevotella are associated with the prognosis of oesophageal squamous cell carcinoma.
Liu Y; Lin Z; Lin Y; Chen Y; Peng XE; He F; Liu S; Yan S; Huang L; Lu W; Xiang Z; Hu Z
J Med Microbiol; 2018 Aug; 67(8):1058-1068. PubMed ID: 29923815
[TBL] [Abstract][Full Text] [Related]
22. Identification of plasma metabolomic profiling for diagnosis of esophageal squamous-cell carcinoma using an UPLC/TOF/MS platform.
Liu R; Peng Y; Li X; Wang Y; Pan E; Guo W; Pu Y; Yin L
Int J Mol Sci; 2013 Apr; 14(5):8899-911. PubMed ID: 23615477
[TBL] [Abstract][Full Text] [Related]
23. Differences in fecal microbial metabolites and microbiota of children with autism spectrum disorders.
Kang DW; Ilhan ZE; Isern NG; Hoyt DW; Howsmon DP; Shaffer M; Lozupone CA; Hahn J; Adams JB; Krajmalnik-Brown R
Anaerobe; 2018 Feb; 49():121-131. PubMed ID: 29274915
[TBL] [Abstract][Full Text] [Related]
24. Identification of serum biomarkers of chemoradiosensitivity in esophageal cancer via the targeted metabolomics approach.
Fujigaki S; Nishiumi S; Kobayashi T; Suzuki M; Iemoto T; Kojima T; Ito Y; Daiko H; Kato K; Shouji H; Honda K; Azuma T; Yoshida M
Biomark Med; 2018 Aug; 12(8):827-840. PubMed ID: 30043633
[TBL] [Abstract][Full Text] [Related]
25. Untargeted metabolomics analysis of esophageal squamous cell cancer progression.
Yang T; Hui R; Nouws J; Sauler M; Zeng T; Wu Q
J Transl Med; 2022 Mar; 20(1):127. PubMed ID: 35287685
[TBL] [Abstract][Full Text] [Related]
26. Structure of gut microbiota and characteristics of fecal metabolites in patients with lung cancer.
Lu X; Xiong L; Zheng X; Yu Q; Xiao Y; Xie Y
Front Cell Infect Microbiol; 2023; 13():1170326. PubMed ID: 37577375
[TBL] [Abstract][Full Text] [Related]
27. [Comparative study on metagenomics of esophageal flora in elderly and middle-aged esophageal squamous cell carcinoma patients].
Liu XB; Gao ZY; Jin S; Gao B; Wang MS; Wu T; Li SB; Tong Q; Zhang JC
Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Mar; 55(3):371-378. PubMed ID: 33730830
[No Abstract] [Full Text] [Related]
28. Gut Microbiome and Serum Metabolome Alterations Associated with Isolated Dystonia.
Ma L; Keng J; Cheng M; Pan H; Feng B; Hu Y; Feng T; Yang F
mSphere; 2021 Aug; 6(4):e0028321. PubMed ID: 34346706
[TBL] [Abstract][Full Text] [Related]
29. A Comparison of Biopsy and Mucosal Swab Specimens for Examining the Microbiota of Upper Gastrointestinal Carcinoma.
Liu AQ; Vogtmann E; Shao DT; Abnet CC; Dou HY; Qin Y; Su Z; Wei WQ; Chen W
Cancer Epidemiol Biomarkers Prev; 2019 Dec; 28(12):2030-2037. PubMed ID: 31519703
[TBL] [Abstract][Full Text] [Related]
30. Integrating 16S RRNA gene sequencing and metabolomics to evaluate the association between gut microbiota and serum metabolites in patients with myositis.
Luo YB; Liu Y; Li Q; Duan H; Luo Z; Yang H; Xu L
J Appl Microbiol; 2022 Oct; 133(4):2547-2559. PubMed ID: 35858765
[TBL] [Abstract][Full Text] [Related]
31. Associations between Diet, the Gut Microbiome, and Short-Chain Fatty Acid Production among Older Caribbean Latino Adults.
Maldonado-Contreras A; Noel SE; Ward DV; Velez M; Mangano KM
J Acad Nutr Diet; 2020 Dec; 120(12):2047-2060.e6. PubMed ID: 32798072
[TBL] [Abstract][Full Text] [Related]
32. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer.
Yang Y; Misra BB; Liang L; Bi D; Weng W; Wu W; Cai S; Qin H; Goel A; Li X; Ma Y
Theranostics; 2019; 9(14):4101-4114. PubMed ID: 31281534
[No Abstract] [Full Text] [Related]
33. Integrating transcriptome and metabolome variability to reveal pathogenesis of esophageal squamous cell carcinoma.
Cheng J; Liu Q; Jin H; Zeng D; Liao Y; Zhao Y; Gao X; Zheng G
Biochim Biophys Acta Mol Basis Dis; 2021 Jan; 1867(1):165966. PubMed ID: 32931889
[TBL] [Abstract][Full Text] [Related]
34. Gut microbiota maturation during early human life induces enterocyte proliferation via microbial metabolites.
Dougherty MW; Kudin O; Mühlbauer M; Neu J; Gharaibeh RZ; Jobin C
BMC Microbiol; 2020 Jul; 20(1):205. PubMed ID: 32652929
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value and functional bioinformatic analysis of spindle- and kinetochore-associated protein 1 in stage IIA esophageal squamous cell carcinoma.
Hu D; Zhang M; Peng Z
J Cancer Res Ther; 2020 Sep; 16(5):1157-1164. PubMed ID: 33004764
[TBL] [Abstract][Full Text] [Related]
36. The gut microbiota and metabolite profiles are altered in patients with spinal cord injury.
Kong G; Zhang W; Zhang S; Chen J; He K; Zhang C; Yuan X; Xie B
Mol Brain; 2023 Feb; 16(1):26. PubMed ID: 36803646
[TBL] [Abstract][Full Text] [Related]
37. Comparison of Fecal Collection Methods for Microbiome and Metabolomics Studies.
Wang Z; Zolnik CP; Qiu Y; Usyk M; Wang T; Strickler HD; Isasi CR; Kaplan RC; Kurland IJ; Qi Q; Burk RD
Front Cell Infect Microbiol; 2018; 8():301. PubMed ID: 30234027
[No Abstract] [Full Text] [Related]
38. Integrative Analysis of Gut Microbiota and Fecal Metabolites in Rats after Prednisone Treatment.
Zhang J; Feng D; Law HK; Wu Y; Zhu GH; Huang WY; Kang Y
Microbiol Spectr; 2021 Dec; 9(3):e0065021. PubMed ID: 34756061
[TBL] [Abstract][Full Text] [Related]
39. Activation of choline kinase drives aberrant choline metabolism in esophageal squamous cell carcinomas.
Ma W; Wang S; Zhang T; Zhang EY; Zhou L; Hu C; Yu JJ; Xu G
J Pharm Biomed Anal; 2018 Jun; 155():148-156. PubMed ID: 29631075
[TBL] [Abstract][Full Text] [Related]
40. Multi-omics profiles of the intestinal microbiome in irritable bowel syndrome and its bowel habit subtypes.
Jacobs JP; Lagishetty V; Hauer MC; Labus JS; Dong TS; Toma R; Vuyisich M; Naliboff BD; Lackner JM; Gupta A; Tillisch K; Mayer EA
Microbiome; 2023 Jan; 11(1):5. PubMed ID: 36624530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
